How Patients Benefit from Growing Intersectionality of Renal and Cardiovascular Diseases
March 4th 2023At ACC.23, our editorial team sat down with a pair of leaders in cardiometabolic health to get their perspective on the growing intersectionality of cardiovascular and chronic kidney disease and how patients have been the beneficiaries of this growing recognition.
Transcatheter Repair Benefits Quality of Life in Patients with Severe Tricuspid Regurgitation
March 4th 2023The TRILUMINATE Pivotal trial reports a reduction in the severity of tricuspid regurgitation with TEER, but no significant difference in survival or hospitalization after one year of follow-up.
Bempedoic Acid Reduces Risk of MACE by 13%, But Proves No Benefit on Cardiovascular Death
March 4th 2023Results of the CLEAR Outcomes trial suggests adherence to bempedoic acid was associated with a 13% relative reduction in incidence of the trial's primary endpoint of 4-point MACE, but no benefit was observed for risk of cardiovascular death or all-cause mortality in the trial.
Don't Miss a Beat: ACC.22 Recap of DIAMOND, SODIUM-HF, and PROMPT-HF
April 5th 2022Don't Miss a Beat hosts Drs. Vaduganathan and Greene provide insight into the results of trials from ACC.22 late-breaking sessions they highlighted in the preview episode they recorded ahead of the American College of Cardiology's 71st Annual Scientific Session.